Small animal imaging: current technology and perspectives for oncological imaging

Advances in the biomedical sciences have been accelerated by the introduction of many new imaging technologies in recent years. With animal models widely used in the basic and pre-clinical sciences, finding ways to conduct animal experiments more accurately and efficiently becomes a key factor in the success and timeliness of research. Non-invasive imaging technologies prove to be extremely valuable tools in performing such studies and have created the recent surge in small animal imaging. This review is focused on three modalities, PET, MR and optical imaging which are available to the scientist for oncological investigations in animals.

[1]  Margaret S. Saha,et al.  Development of a novel radiation imaging detector system for in vivo gene imaging in small animal studies , 1996, IEEE Nuclear Science Symposium Conference Record.

[2]  J R Griffiths,et al.  Effects of nicotinamide and carbogen on tumour oxygenation, blood flow, energetics and blood glucose levels , 2000, British Journal of Cancer.

[3]  D. Weber,et al.  Ultra-high-resolution imaging of small animals: Implications for preclinical and research studies , 1999, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[4]  S. Cherry,et al.  The Use of MicroPET for the Development of Neural Repair Therapeutics: Studies in Epilepsy and Lesion Models , 2001, Journal of clinical pharmacology.

[5]  H. Choy,et al.  Enhancement of Tumor Oxygenation and Radiation Response by the Allosteric Effector of Hemoglobin, RSR13 , 2001, Radiation research.

[6]  J E Mortimer,et al.  Positron tomographic assessment of estrogen receptors in breast cancer: comparison with FDG-PET and in vitro receptor assays. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[7]  F. Sarkar,et al.  Magnetic Resonance Imaging to Measure Therapeutic Response Using an Orthotopic Model of Human Pancreatic Cancer , 2000, Pancreas.

[8]  S. Cherry,et al.  Imaging adenoviral-directed reporter gene expression in living animals with positron emission tomography. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[9]  M J Paulus,et al.  High resolution computed tomography and MRI for monitoring lung tumor growth in mice undergoing radioimmunotherapy: correlation with histology. , 2000, Medical physics.

[10]  Britton Chance,et al.  Breast imaging technology: Probing physiology and molecular function using optical imaging - applications to breast cancer , 2000, Breast Cancer Research.

[11]  R. Weissleder,et al.  Detection of lymph node metastases by contrast‐enhanced MRI in an experimental model , 2002, Magnetic resonance in medicine.

[12]  S. Achilefu,et al.  Novel fluorescent contrast agents for optical imaging of in vivo tumors based on a receptor-targeted dye-peptide conjugate platform. , 2001, Journal of biomedical optics.

[13]  T J Spinks,et al.  Three-dimensional performance of a small-diameter positron emission tomograph. , 1997, Physics in medicine and biology.

[14]  A. Del Guerra,et al.  YAP-PET: first results of a small animal positron emission tomograph based on YAP:Ce finger crystals , 1998 .

[15]  Simon R. Cherry,et al.  In vivo imaging of neuronal activation and plasticity in the rat brain by high resolution positron emission tomography (microPET) , 2000, Nature Biotechnology.

[16]  Roger Lecomte,et al.  Design and engineering aspects of a high resolution positron tomograph for small animal imaging , 1994 .

[17]  Simon R. Cherry,et al.  Deficits in Striatal Dopamine D2 Receptors and Energy Metabolism Detected by in Vivo MicroPET Imaging in a Rat Model of Huntington's Disease , 2000, Experimental Neurology.

[18]  R. Weissleder Scaling down imaging: molecular mapping of cancer in mice , 2002, Nature Reviews Cancer.

[19]  S. Larson,et al.  Ga-66 labeled somatostatin analogue DOTA-DPhe1-Tyr3-octreotide as a potential agent for positron emission tomography imaging and receptor mediated internal radiotherapy of somatostatin receptor positive tumors. , 2002, Nuclear medicine and biology.

[20]  A. Yeung,et al.  Photoangioplasty with local motexafin lutetium delivery reduces macrophages in a rabbit post-balloon injury model. , 2001, Cardiovascular research.

[21]  S. Gambhir,et al.  Imaging gene expression: Principles and assays , 1999, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[22]  H. van den Bergh,et al.  Antibody–fluorescein conjugates for photoimmunodiagnosis of human colon carcinoma in nude mice , 1991, Cancer.

[23]  Alan J. Fischman,et al.  Development of a small animal PET imaging device with resolution approaching 1 mm , 1999 .

[24]  J. Barrio,et al.  Assays for noninvasive imaging of reporter gene expression. , 1999, Nuclear medicine and biology.

[25]  Simon R. Cherry,et al.  Comparison of 3-D maximum a posteriori and filtered backprojection algorithms for high-resolution animal imaging with microPET , 2000, IEEE Transactions on Medical Imaging.

[26]  E. Blakely,et al.  Boronated protoporphyrin (BOPP): localization in lysosomes of the human glioma cell line SF-767 with uptake modulated by lipoprotein levels. , 1999, International journal of radiation oncology, biology, physics.

[27]  E. Marinelli,et al.  Synthesis, characterization, and imaging performance of a new class of macrocyclic hepatobiliary MR contrast agents. , 2000, Investigative radiology.

[28]  Wolfhard Semmler,et al.  Macromolecular Contrast Agents for Optical Imaging of Tumors: Comparison of Indotricarbocyanine-labeled Human Serum Albumin and Transferrin¶ , 2000, Photochemistry and photobiology.

[29]  S R Cherry,et al.  Detector development for microPET II: a 1 microl resolution PET scanner for small animal imaging. , 2001, Physics in medicine and biology.

[30]  R. Kauppinen,et al.  Monitoring thymidine kinase and ganciclovir-induced changes in rat malignant glioma in vivo by nuclear magnetic resonance imaging. , 1998, Cancer gene therapy.

[31]  David E Reichert,et al.  Metal complexes as diagnostic tools , 1999 .

[32]  O. Nalcioglu,et al.  Effect of vasodilator hydralazine on tumor microvascular random flow and blood volume as measured by intravoxel incoherent motion (IVIM) weighted MRI in conjunction with Gd-DTPA-Albumin enhanced MRI. , 2001, Magnetic resonance imaging.

[33]  Fluorescence Imaging During Photodynamic Therapy of Experimental Tumors in Mice Sensitized with Disulfonated Aluminum Phthalocyanine¶ , 2000, Photochemistry and photobiology.

[34]  M J Paulus,et al.  High resolution X-ray computed tomography: an emerging tool for small animal cancer research. , 2000, Neoplasia.

[35]  Albert Cerussi,et al.  Noninvasive functional optical spectroscopy of human breast tissue , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[36]  J. Zwischenberger,et al.  Development of a human to murine orthotopic xenotransplanted lung cancer model. , 2000, Journal of investigative surgery : the official journal of the Academy of Surgical Research.

[37]  Adriaan A. Lammertsma,et al.  The potential of high-resolution positron emission tomography to monitor striatal dopaminergic function in rat models of disease , 1996 .

[38]  N. Rouze,et al.  Design of IndyPET-II, a high-resolution, high-sensitivity dedicated research scanner , 2001, 2001 IEEE Nuclear Science Symposium Conference Record (Cat. No.01CH37310).

[39]  T. Visser,et al.  Pre‐clinical comparison of [DTPA0] octreotide, [DTPA0,Tyr3] octreotide and [DOTA0,Tyr3] octreotide as carriers for somatostatin receptor‐targeted scintigraphy and radionuclide therapy , 1998, International journal of cancer.

[40]  M. Black,et al.  A mutant herpes simplex virus type 1 thymidine kinase reporter gene shows improved sensitivity for imaging reporter gene expression with positron emission tomography. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[41]  Kazuo Hayashi,et al.  High Resolution X-Ray Computed Tomography. , 1993 .

[42]  Ralph Weissleder,et al.  In vivo molecular target assessment of matrix metalloproteinase inhibition , 2001, Nature Medicine.

[43]  D. Shahbazi-Gahrouei,et al.  In vivo studies of Gd‐DTPA‐monoclonal antibody and gd‐porphyrins: Potential magnetic resonance imaging contrast agents for melanoma , 2001, Journal of magnetic resonance imaging : JMRI.

[44]  Martin O Leach,et al.  Breast imaging technology: Application of magnetic resonance imaging to angiogenesis in breast cancer , 2000, Breast Cancer Research.

[45]  J. Lewis,et al.  Comparison of four 64Cu-labeled somatostatin analogues in vitro and in a tumor-bearing rat model: evaluation of new derivatives for positron emission tomography imaging and targeted radiotherapy. , 1999, Journal of medicinal chemistry.

[46]  M. Décorps,et al.  A new gadolinium‐based contrast agent for magnetic resonance imaging of brain tumors: Kinetic study on a C6 rat glioma model , 2001, Journal of magnetic resonance imaging : JMRI.

[47]  Peter J. Fish,et al.  Lesion classification using skin patterning , 2000, Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging.

[48]  H Stepp,et al.  Photodetection of cervical intraepithelial neoplasia using 5‐aminolevulinic acid–induced porphyrin fluorescence , 2000, Cancer.

[49]  R Weissleder,et al.  Novel gliosarcoma cell line expressing green fluorescent protein: A model for quantitative assessment of angiogenesis. , 1998, Microvascular research.

[50]  H. Atkins,et al.  Pinhole SPECT: an approach to in vivo high resolution SPECT imaging in small laboratory animals. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[51]  M. Rafecas,et al.  Characterization and processing of inter-crystal scatter in a dual layer, high resolution LSO-APD-PET , 2001, 2001 IEEE Nuclear Science Symposium Conference Record (Cat. No.01CH37310).

[52]  B. Allison,et al.  Evidence for low-density lipoprotein receptor-mediated uptake of benzoporphyrin derivative. , 1994, British Journal of Cancer.

[53]  B. Ross,et al.  Magnetic Resonance Imaging of Ethyl-nitrosourea-induced Rat Gliomas: A Model for Experimental Therapeutics of Low-grade Gliomas , 2001, Journal of Neuro-Oncology.

[54]  H. Bergh,et al.  Antibody-indocyanin conjugates for immunophotodetection of human squamous cell carcinoma in nude mice. , 1994, Cancer research.

[55]  R Myers,et al.  The biological application of small animal PET imaging. , 2001, Nuclear medicine and biology.

[56]  D A Benaron,et al.  Imaging transgenic animals. , 1999, Annual review of biomedical engineering.

[57]  Hiroyuki Okada,et al.  A high resolution animal PET scanner using compact PS-PMT detectors , 1996 .

[58]  Jean-Philippe Galons,et al.  Early response of prostate carcinoma xenografts to docetaxel chemotherapy monitored with diffusion MRI. , 2002, Neoplasia.

[59]  R. Boyle,et al.  Functionalized diphenylchlorins and bacteriochlorins: their synthesis and bioconjugation for targeted photodynamic therapy and tumour cell imaging , 2000 .

[60]  A. Young,et al.  Chromophores in human skin. , 1997, Physics in medicine and biology.

[61]  T. V. van Berkel,et al.  Properties of incorporation, redistribution, and integrity of porphyrin-low-density lipoprotein complexes. , 1993, Biochemistry.

[62]  W C Eckelman,et al.  High resolution PET, SPECT and projection imaging in small animals. , 2001, Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society.

[63]  M. Bock,et al.  Magnetic Resonance Imaging of Nude Mice With Heterotransplanted High-Grade Squamous Cell Carcinomas: Use of a Low-Loaded, Covalently Bound Gd-Hsa Conjugate as Contrast Agent With High Tumor Affinity , 2002, Investigative radiology.

[64]  C. Rinker-Schaeffer,et al.  Differentiation of nonmetastatic and metastatic rodent prostate tumors with high spectral and spatial resolution MRI , 2001, Magnetic resonance in medicine.

[65]  C. L. Hutchinson,et al.  Fluorescence and Absorption Contrast Mechanisms for Biomedical Optical Imaging Using Frequency‐Domain Techniques , 1997, Photochemistry and photobiology.

[66]  T. Jones,et al.  Positron emission tomography (PET) methodology for small animals and its application in radiopharmaceutical preclinical investigation. , 1998, Nuclear medicine and biology.

[67]  M. Welch,et al.  Positron emission tomography with 2-[18F]Fluoro-2-deoxy-D-glucose and 16alpha-[18F]fluoro-17beta-estradiol in breast cancer: correlation with estrogen receptor status and response to systemic therapy. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

[68]  S. Cherry,et al.  Performance evaluation of microPET: a high-resolution lutetium oxyorthosilicate PET scanner for animal imaging. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[69]  N. van Bruggen,et al.  Assessing tumor angiogenesis using macromolecular MR imaging contrast media , 1997, Journal of magnetic resonance imaging : JMRI.

[70]  W. Beecken,et al.  Sonographic evaluation of orthotopic bladder tumors in mice treated with TNP-470, an angiogenic inhibitor. , 2001, Academic radiology.

[71]  J. M. Taylor,et al.  Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors. , 2000, Journal of the National Cancer Institute.

[72]  Wai-Fung Cheong,et al.  PILOT COMPARISON OF LIGHT-BASED OPTICAL TOMOGRAPHY VERSUS ULTRASOUND FOR REAL-TIME IMAGING OF NEONATAL INTRAVENTRICULAR HEMORRHAGE. † 1189 , 1996, Pediatric Research.

[73]  S S Gambhir,et al.  High-resolution microPET imaging of carcinoembryonic antigen-positive xenografts by using a copper-64-labeled engineered antibody fragment. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[74]  D. Slosman,et al.  Carcinoembryonic antigen expression, antibody localisation and immunophotodetection of human colon cancer liver metastases in nude mice: A model for radioimmunotherapy , 1996, International journal of cancer.

[75]  T S Smith,et al.  Three‐dimensional microimaging (MRμI and μCT), finite element modeling, and rapid prototyping provide unique insights into bone architecture in osteoporosis , 2001, The Anatomical record.

[76]  R. Felix,et al.  Contrast‐enhanced high resolution magnetic resonance imaging of pigmented malignant melanoma using Mn‐TPPS4 and Gd‐DTPA: experimental results , 2000, Melanoma research.

[77]  R. Kauppinen,et al.  Characterization of a new animal model for human renal cell carcinoma. , 2000, In vivo.

[78]  A. P. Jeavons,et al.  A 3D HIDAC-PET camera with sub-millimetre resolution for imaging small animals , 1998 .

[79]  James F. Young,et al.  MicroPET: a high resolution PET scanner for imaging small animals , 1996, IEEE Nuclear Science Symposium Conference Record.

[80]  Simon R. Cherry,et al.  Optical fiber readout of scintillator arrays using a multi-channel PMT: a high resolution PET detector for animal imaging , 1995 .

[81]  Michael E. Phelps,et al.  Ex vivo cell labeling with 64Cu–pyruvaldehyde-bis(N4-methylthiosemicarbazone) for imaging cell trafficking in mice with positron-emission tomography , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[82]  M. Dewhirst,et al.  In vivo BOLD contrast MRI mapping of subcutaneous vascular function and maturation: Validation by intravital microscopy , 2001, Magnetic resonance in medicine.

[83]  R Myers,et al.  The effects of donor stage on the survival and function of embryonic striatal grafts in the adult rat brain II. Correlation between positron emission tomography and reaching behaviour , 1997, Neuroscience.

[84]  S. Cherry,et al.  Fundamentals of Positron Emission Tomography and Applications in Preclinical Drug Development , 2001, Journal of clinical pharmacology.

[85]  P Rüegsegger,et al.  Assessment of cancellous bone mechanical properties from micro-FE models based on micro-CT, pQCT and MR images. , 1998, Technology and health care : official journal of the European Society for Engineering and Medicine.

[86]  S S Gambhir,et al.  Use of positron emission tomography in animal research. , 2001, ILAR journal.

[87]  K. Zilles,et al.  Recent results of the TierPET scanner , 1999, 1999 IEEE Nuclear Science Symposium. Conference Record. 1999 Nuclear Science Symposium and Medical Imaging Conference (Cat. No.99CH37019).

[88]  L. Svaasand,et al.  Non-invasive in vivo characterization of breast tumors using photon migration spectroscopy. , 2000, Neoplasia.

[89]  Eva M. Sevick-Muraca,et al.  Pharmacokinetics of ICG and HPPH-car for the Detection of Normal and Tumor Tissue Using Fluorescence, Near-infrared Reflectance Imaging: A Case Study¶ , 2000, Photochemistry and photobiology.

[90]  P. Smith-Jones,et al.  The somatostatin receptor-targeted radiotherapeutic [90Y-DOTA-dPhe1,Tyr3]octreotide (90Y-SMT 487) eradicates experimental rat pancreatic CA 20948 tumours , 1998, European Journal of Nuclear Medicine.

[91]  Markus Cremer,et al.  Evaluation of the TierPET system , 1998 .

[92]  S R Cherry,et al.  Quantitative Assessment of Longitudinal Metabolic Changes In Vivo after Traumatic Brain Injury in the Adult Rat using FDG-MicroPET , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[93]  V. Ntziachristos,et al.  Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancement. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[94]  C Zimmer,et al.  Magnetic labeling of activated microglia in experimental gliomas. , 2001, Neoplasia.

[95]  O. Nalcioglu,et al.  Prediction of gene therapy-induced tumor size changes by the vascularity changes measured using dynamic contrast-enhanced MRI. , 2000, Magnetic resonance imaging.

[96]  N. Satyamurthy,et al.  8-[18F]Fluoropenciclovir: an improved reporter probe for imaging HSV1-tk reporter gene expression in vivo using PET. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[97]  Arion F. Chatziioannou,et al.  Molecular imaging of small animals with dedicated PET tomographs , 2001, European Journal of Nuclear Medicine and Molecular Imaging.

[98]  A. Del Guerra,et al.  First in vivo studies on rats with the YAPPET scanner , 1999, 1999 IEEE Nuclear Science Symposium. Conference Record. 1999 Nuclear Science Symposium and Medical Imaging Conference (Cat. No.99CH37019).

[99]  Gary D. Hutchins,et al.  IndyPET-a high resolution, high sensitivity dedicated research scanner , 1999, 1999 IEEE Nuclear Science Symposium. Conference Record. 1999 Nuclear Science Symposium and Medical Imaging Conference (Cat. No.99CH37019).

[100]  M. O'dorisio,et al.  Disseminated neuroblastoma in the nude rat: A xenograft model of human malignancy , 1996, Cancer.

[101]  W. Semmler,et al.  Receptor-targeted optical imaging of tumors with near-infrared fluorescent ligands , 2001, Nature Biotechnology.

[102]  P. Allen,et al.  Dynamic visualization of a joint-specific autoimmune response through positron emission tomography , 2002, Nature Immunology.

[103]  B. Wilson,et al.  In Vivo Fluorescence Spectroscopy and Imaging for Oncological Applications , 1998, Photochemistry and photobiology.

[104]  H. Müller-Gärtner,et al.  High Resolution SPECT in Small Animal Research , 2001, Reviews in the neurosciences.

[105]  M E Easterly,et al.  A review of high-resolution X-ray computed tomography and other imaging modalities for small animal research. , 2001, Lab animal.

[106]  Magdalena Rafecas,et al.  A prototype high-resolution animal positron tomograph with avalanche photodiode arrays and LSO crystals , 2001, European Journal of Nuclear Medicine.

[107]  S. Cherry,et al.  PET imaging of transgene expression , 2000, Biological Psychiatry.

[108]  R. Hoffman,et al.  Visualization of GFP-expressing tumors and metastasis in vivo. , 2001, BioTechniques.

[109]  Daniel J. Hawrysz,et al.  Developments toward diagnostic breast cancer imaging using near-infrared optical measurements and fluorescent contrast agents. , 2000, Neoplasia.

[110]  T. Pietsch,et al.  Animal model of human medulloblastoma: clinical, magnetic resonance imaging, and histopathological findings after intra-cisternal injection of MHH-MED-1 cells into nude rats. , 1997, Medical and pediatric oncology.

[111]  S. Cherry,et al.  Synthesis of 8-[18F]fluoroguanine derivatives: in vivo probes for imaging gene expression with positron emission tomography ☆ , 2000 .

[112]  Zhang Shuping,et al.  First results from a prototype PET scanner using BaF/sub 2/ scintillator and photosensitive wire chambers , 1994, Proceedings of 1994 IEEE Nuclear Science Symposium - NSS'94.

[113]  William C. Broaddus,et al.  Determination of intracranial tumor volumes in a rodent brain using magnetic resonance imaging, Evans Blue, and histology: a comparative study , 2000, IEEE Transactions on Biomedical Engineering.

[114]  M. Seville,et al.  A whole new way of looking at things: The use of Dark Reader technology to detect fluorophors , 2001, Electrophoresis.

[115]  S. Larson,et al.  Imaging transgene expression with radionuclide imaging technologies. , 2000, Neoplasia.

[116]  D Artemov,et al.  Vascular differences detected by MRI for metastatic versus nonmetastatic breast and prostate cancer xenografts. , 2001, Neoplasia.

[117]  Michael R Hamblin,et al.  Photosensitizer targeting in photodynamic therapy. II. Conjugates of haematoporphyrin with serum lipoproteins. , 1994, Journal of photochemistry and photobiology. B, Biology.

[118]  Marleen Verhoye,et al.  Assessment of the neovascular permeability in glioma xenografts by dynamic T1 MRI with Gadomer‐17 , 2002, Magnetic Resonance in Medicine.

[119]  J. Seidel,et al.  Initial results from a PET/planar small animal imaging system , 1998 .

[120]  R. N. Goble,et al.  Performance evaluation of the microPET P4: a PET system dedicated to animal imaging. , 2001, Physics in medicine and biology.

[121]  Anthony J. Durkin,et al.  In vivo Fluorescence Spectroscopy of Nonmelanoma Skin Cancer¶ , 2001, Photochemistry and photobiology.

[122]  P Bruyndonckx,et al.  A fully 3D small PET scanner. , 1992, Physics in medicine and biology.

[123]  P. Humphrey,et al.  Impaired prostate tumorigenesis in Egr1-deficient mice , 2001, Nature Medicine.

[124]  Bernd J. Pichler,et al.  Studies with a prototype high resolution PET scanner based on LSO-APD modules , 1997 .

[125]  R Myers,et al.  Radio-imaging in small animals , 1999, Journal of psychopharmacology.

[126]  P. Jiang,et al.  Whole-body and intravital optical imaging of angiogenesis in orthotopically implanted tumors , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[127]  T J Spinks,et al.  The design and physical characteristics of a small animal positron emission tomograph. , 1995, Physics in medicine and biology.

[128]  S Nioka,et al.  Optical imaging of breast tumor by means of continuous waves. , 1997, Advances in experimental medicine and biology.

[129]  A. Rehemtulla,et al.  Diffusion MRI detects early events in the response of a glioma model to the yeast cytosine deaminase gene therapy strategy , 2000, Gene Therapy.

[130]  Adriaan A. Lammertsma,et al.  In vivo saturation kinetics of two dopamine transporter probes measured using a small animal positron emission tomography scanner , 1997, Journal of Neuroscience Methods.

[131]  S. Achilefu,et al.  Novel receptor-targeted fluorescent contrast agents for in vivo tumor imaging. , 2000, Investigative radiology.

[132]  L Ploux,et al.  In vivo radiolabel quantification in small-animal models. , 1998, Nuclear medicine and biology.

[133]  Gerald G. Miller,et al.  Characterization of a novel transplantable orthotopic rat bladder transitional cell tumour model , 1999, British Journal of Cancer.

[134]  R. Myers,et al.  Evaluation of [11C]RTI-121 as a selective radioligand for PET studies of the dopamine transporter. , 1996, Nuclear Medicine and Biology.

[135]  Anderson,et al.  Utilization of metabolic, transport and receptor-mediated processes to deliver agents for cancer diagnosis. , 1999, Advanced drug delivery reviews.

[136]  V. Ntziachristos,et al.  Hydrophilic Cyanine Dyes as Contrast Agents for Near-infrared Tumor Imaging: Synthesis, Photophysical Properties and Spectroscopic In vivo Characterization¶ , 2000, Photochemistry and photobiology.

[137]  R Weissleder,et al.  Near-infrared optical imaging of protease activity for tumor detection. , 1999, Radiology.

[138]  Z. Bhujwalla,et al.  Real‐time measurements of cellular oxygen consumption, pH, and energy metabolism using nuclear magnetic resonance spectroscopy , 2001, Magnetic resonance in medicine.

[139]  H. D'Arceuil,et al.  SIMULTANEOUS TIME-OF-FLIGHT ADJUSTED (TOFA) NEAR-INFRARED SPECTROSCOPY AND MAGNETIC RESONANCE IMAGING OF IMMATURE RABBIT HYPOXIC-ISCHEMIC ENCEPHALOPATHY(HIE). • 2264 , 1996, Pediatric Research.

[140]  T. Yamashita,et al.  A high resolution PET for animal studies , 1991, Conference Record of the 1991 IEEE Nuclear Science Symposium and Medical Imaging Conference.

[141]  J. S. Reynolds,et al.  Imaging of Spontaneous Canine Mammary Tumors Using Fluorescent Contrast Agents , 1999, Photochemistry and photobiology.

[142]  J. Schotland Continuous-wave diffusion imaging , 1997 .

[143]  A. Villringer,et al.  Non-invasive optical spectroscopy and imaging of human brain function , 1997, Trends in Neurosciences.

[144]  J. Mourant,et al.  Ultraviolet and visible spectroscopies for tissue diagnostics: fluorescence spectroscopy and elastic-scattering spectroscopy. , 1997, Physics in medicine and biology.

[145]  C. Contag,et al.  Noninvasive assessment of tumor cell proliferation in animal models. , 1999, Neoplasia.

[146]  M. Brechbiel,et al.  Pharmacokinetics and enhancement patterns of macromolecular MR contrast agents with various sizes of polyamidoamine dendrimer cores , 2001, Magnetic resonance in medicine.

[147]  Jurgen Seidel,et al.  Resolution uniformity and sensitivity of the NIH ATLAS small animal PET scanner: comparison to simulated LSO scanners without depth-of-interaction capability , 2001 .

[148]  D L Farkas,et al.  Tumor Detection and Visualization Using Cyanine Fluorochrome‐Labeled Antibodies , 1997, Biotechnology progress.

[149]  Willem M. Star,et al.  Protoporphyrin IX Fluorescence Kinetics and Localization after Topical Application of ALA Pentyl Ester and ALA on Hairless Mouse Skin with UVB-Induced Early Skin Cancer , 2000, Photochemistry and photobiology.

[150]  R. Langlois,et al.  Low-density lipoprotein-bound aluminum sulfophthalocyanine: targeting tumor cells for photodynamic therapy , 2001 .

[151]  E P Krenning,et al.  Comparison of (111)In-labeled somatostatin analogues for tumor scintigraphy and radionuclide therapy. , 1998, Cancer research.

[152]  T. Helbich,et al.  Quantitative gadopentetate‐enhanced MRI of breast tumors: Testing of different analytic methods , 2000, Magnetic resonance in medicine.

[153]  K. Brindle,et al.  Differential sensitivity of two adenocarcinoma xenografts to the anti‐vascular drugs combretastatin A4 phosphate and 5,6‐dimethylxanthenone‐4‐acetic acid, assessed using MRI and MRS , 2002, NMR in biomedicine.

[154]  S R Cherry,et al.  Design and evaluation of an LSO PET detector for breast cancer imaging. , 2000, Medical physics.

[155]  C. Osborne,et al.  Tumor receptor imaging: proceedings of the National Cancer Institute workshop, review of current work, and prospective for further investigations. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

[156]  D L Farkas,et al.  Cyanine fluorochrome-labeled antibodies in vivo: assessment of tumor imaging using Cy3, Cy5, Cy5.5, and Cy7. , 1998, Cancer detection and prevention.

[157]  P. So,et al.  Two-Photon deep tissue ex vivo imaging of mouse dermal and subcutaneous structures. , 1998, Optics Express.

[158]  Non-invasive analysis of rat ovarian angiogenesis by MRI , 2002, Molecular and Cellular Endocrinology.

[159]  James W Fleshman,et al.  Copper-64-pyruvaldehyde-bis(N(4)-methylthiosemicarbazone) for the prevention of tumor growth at wound sites following laparoscopic surgery: monitoring therapy response with microPET and magnetic resonance imaging. , 2002, Cancer research.

[160]  R. J. Fornaris,et al.  3D ultrasonic mapping of the microvasculature , 1996, 1996 IEEE Ultrasonics Symposium. Proceedings.

[161]  R. Weissleder,et al.  In vivo imaging of tumors with protease-activated near-infrared fluorescent probes , 1999, Nature Biotechnology.

[162]  W Sibbett,et al.  The Application of a Compact Multispectral Imaging System with Integrated Excitation Source to In vivo Monitoring of Fluorescence During Topical Photodynamic Therapy of Superficial Skin Cancers ¶ , 2001, Photochemistry and photobiology.

[163]  R. Jain,et al.  Interstitial transport of rabbit and sheep antibodies in normal and neoplastic tissues. , 1990, Cancer research.

[164]  M E Phelps,et al.  Design features and performance of a PET system for animal research. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[165]  D. Goldenberg Cancer imaging and therapy with radiolabeled antibodies. , 1991, Advances in experimental medicine and biology.

[166]  B. Vojnovic,et al.  Evaluation of the anti‐vascular effects of combretastatin in rodent tumours by dynamic contrast enhanced MRI , 2002, NMR in biomedicine.

[167]  H. Al-Hallaq,et al.  MRI measurements correctly predict the relative effects of tumor oxygenating agents on hypoxic fraction in rodent BA1112 tumors. , 2000, International journal of radiation oncology, biology, physics.

[168]  R J Ott,et al.  Classification of reflectance spectra from pigmented skin lesions, a comparison of multivariate discriminant analysis and artificial neural networks , 2000, Physics in medicine and biology.

[169]  Steven L. Jacques,et al.  In vivo fluorescence spectroscopy and imaging of human skin tumors. , 1995 .

[170]  E. Sevick-Muraca,et al.  Fluorescence-enhanced absorption imaging using frequency-domain photon migration: tolerance to measurement error. , 2001, Journal of biomedical optics.

[171]  J. Kennedy,et al.  An Affordable, Portable Fluorescence Imaging Device for Skin Lesion Detection Using a Dual Wavelength Approach for Image Contrast Enhancement and Aminolaevulinic Acid-induced Protoporphyrin IX. Part II. In Vivo Testing , 2001, Lasers in Medical Science.

[172]  Joonyoung Kim,et al.  DOTA-D-Tyr(1)-octreotate: a somatostatin analogue for labeling with metal and halogen radionuclides for cancer imaging and therapy. , 2002, Bioconjugate chemistry.

[173]  M. Samii,et al.  A New Xenograft Model of Primary Central Nervous System Lymphoma , 1999, Journal of Neuro-Oncology.

[174]  M. Subbarayan,et al.  Water-soluble 99mTc-labeled dendritic novel porphyrins tumor imaging and diagnosis. , 2001, Biochemical and biophysical research communications.

[175]  B G Zagar,et al.  Ultrasonic mapping of the microvasculature: signal alignment. , 1998, Ultrasound in medicine & biology.

[176]  N. Satyamurthy,et al.  Direct correlation between positron emission tomographic images of two reporter genes delivered by two distinct adenoviral vectors , 2001, Gene Therapy.

[177]  J. Douillard,et al.  Interleukin‐2/sodium butyrate treatment cures rats bearing liver tumors after acquired 5‐fluorouracil resistance , 1998, International journal of cancer.

[178]  Michael J. Paulus,et al.  High-resolution x-ray CT screening of mutant mouse models , 2000, Photonics West - Biomedical Optics.

[179]  B Palcic,et al.  Detection and localization of early lung cancer by fluorescence bronchoscopy , 2000, Cancer.

[180]  U. Schmidt-Erfurth,et al.  Photodynamic targeting of human retinoblastoma cells using covalent low-density lipoprotein conjugates. , 1997, British Journal of Cancer.